Search All News
A new initiative led by Columbia University and the n-Lorem Foundation will develop personalized therapies for individuals with "nano-rare" genetic forms of ALS and treat them for free, for life.
Parkinson’s patients and their families are increasingly turning to genetic testing to learn more about their disease or risk of passing it on. But testing is complex, and counseling is advised.
COVID patients who remain unresponsive after receiving respiratory support may require long time periods to regain consciousness; delays are related to blood oxygen levels.
A newly discovered protein tangle has been associated with multiple neurodegenerative diseases and may have a role in causing the diseases.
- October 3, 2017
Scientists propose a new model for Alzheimer's disease that may explain the high failure rate of recent clinical trials.
- September 18, 2017
A cellular defense against protein aggregates suppresses ALS in early stages but later hastens spread of the disease, a study in mice suggests.
- August 29, 2017
Age-related memory loss was reversed by boosting blood levels of osteocalcin, a hormone produced by bone cells, in mice.
- July 26, 2017
Columbia neurologist Denise Chou, MD, explains a new breakthrough in headache medicine: the first targeted preventive therapy for migraine.
- July 17, 2017
A new study suggests how nutrients found in brain-healthy foods can reduce inflammation and lower Alzheimer's risk.
- June 21, 2017
Researchers have found the first direct evidence that autoimmunity plays a role in Parkinson’s disease.
- May 25, 2017
Certain women with preeclampsia are more likely to have a pregnancy-related stroke, finds a new study led by Columbia neurologists.
- May 19, 2017
Neurosurgeon Sameer Sheth uses deep brain stimulation to treat depression in patients who have not been helped with other therapies.
- May 15, 2017
Spinal muscular atrophy is partly due to defects in the sensory neuron synapses that activate motor neurons. Symptoms may be reduced by improving synapse function.